The Biotech industry is still an emerging application area for simulation techniques. This paper describes the hierarchical discrete event simulation efforts at Bayer Corporation's Berkeley facility that manufactures secondgeneration recombinant DNA technology based drug, Kogenate-FS
Prasad V. Saraph